Monday, June 6, 2011

OncoLink at ASCO
OncoLink reporters provide in-depth coverage of scientific presentations from Annual ASCO Meeting.

A phase III randomized trial of intermittent versus continuous androgen suppression for PSA progression after radical therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/ UK Intercontinental Trial CRUKE/01/013)
A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC)
Cancer diagnosis as a risk factor for personal bankruptcy
Effect of yoga on QOL, cortisol rhythm, and HRV for women with breast cancer undergoing radiotherapy
Impact of out-of-pocket expenses on cancer care
Is hormone replacement therapy (HRT) following risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 (B1)- and BRCA2 (B2)-mutation carriers associated with an increased risk of breast cancer?
NCIC-CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer
The impact of socioeconomic status on cancer care and survival
Toward a rationale strategy for prostate cancer screening based on long term risk of prostate cancer metastases and death: data from a large, unscreened, population-based cohort followed for up to 30 years